What to do? Both the Romanow commission and the Kirby committee on health care-to say nothing of reports from other experts recommended the creation of a national drug agency. Instead of each province having its own list of approved drugs , bureaucracy, procedures and limited bargaining power, all would pool resources , work with Ottawa, and create a national institution.
42.
But “national” doesn't have to mean that. “National” could mean interprovincial-provinces combining efforts to create one body.
Either way, one benefit of a “national” organization would be to negotiate better prices, if possible, with drug manufacturers. Instead of having one province-or a series of hospitals within a province-negotiate a price for a given drug on the provincial list, the national agency would negotiate on behalf of all provinces.
Rather than, say, Quebec, negotiating on behalf of seven million people, the national agency would negotiate on behalf 31 million people. Basic economics suggests the greater the potential consumers, the higher the likelihood of a better price.
用户登录 
新用户注册 
